ATLANTA, March 06, 2018 -- NFANT Labs has been named a finalist in the South by Southwest (SXSW) Impact Pediatric Health competition that will be held March 9th in Austin, TX.
Created four years ago by eight of the top U.S. News & World Report “Best Children’s Hospitals,” Impact Pediatric Health is a one-of-a-kind pitch competition to help showcase and support the best pediatric health care innovations. Representatives from all eight hospitals, as well as venture capitalists and industry leaders, will hear pitches from all of the finalists in order to choose an overall winner. This select group of companies will also have the opportunity to meet with hospitals one-on-one in order to foster relationships and implement solutions to solve real world problems.
NFANT Labs is uniquely suited for Impact’s area of focus this year: prematurity, digital health and medtech. NFANT Labs developed nfant Feeding Solution, the first FDA cleared IoT device for the NICU and most recently, nfant Analytics, a Machine Learning and reporting platform aimed at leveraging objective IoT data to help infants struggling to feed.
“It’s an honor to be chosen as a finalist for this prestigious award,” said Lou Malice, NFANT’s CEO. “With our products already implemented into hospitals across the country, NFANT is poised to make a large and immediate impact in the lives of these infants and their families. We are excited for the opportunity to work with these top-notch children’s hospitals to make predictive analytics a reality in neonatal feeding care.”
Participating hospitals include Children’s Healthcare of Atlanta, Boston Children’s Hospital, Cincinnati Children’s Hospital, Children’s Hospital Los Angeles, Children’s Hospital of Philadelphia, Seattle Children’s Hospital, Stanford Children’s Health and Texas Children’s Hospital.
About NFANT Labs
NFANT Labs is an emerging digital health and medical device company based in Atlanta, Georgia, dedicated to infant feeding. nfant Feeding Solution, the first FDA-cleared "Internet of Things" (IoT) medical device for the NICU, and nfant Analytics, a Machine Learning and reporting platform, give clinicians, hospital providers and payers insight to infant progress and path to discharge. Improving the standard of feeding care by collecting objective data and tracking feeding progression has the potential to shorten NICU stays, reduce readmissions and deliver substantial savings. For more information about NFANT Labs and all of its products please visit www.nfant.com.
Contact: [email protected] – 800.761.7601


Samsung Electronics Shares Jump on HBM4 Mass Production Report
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Washington Post Publisher Will Lewis Steps Down After Layoffs
Anta Sports Expands Global Footprint With Strategic Puma Stake 



